Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 1, 2009, Pages 256-260

  Krishnakumari, Viswanatha ^a   Rangaraj, Nandini ^a   Nagaraj, Ramakrishnan ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; PROTEIN PHD1; PROTEIN PHD2; PROTEIN PHD3; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CARBOXY TERMINAL SEQUENCE; CONFOCAL MICROSCOPY; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; BETA-DEFENSINS; CANDIDA ALBICANS; HUMANS;

EID: 59749096989     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00470-08     Document Type: Article

References (36)

1. Agerberth, B., and G. H. Gudmundsson. 2006. Host antimicrobial defence peptides in human disease. Curr. Top. Microbiol. Immunol. 306:67-90.
2. Bals, R., X. Wang, Z. Wu, T. Freeman, V. Bafna, M. Zasloff, and J. M. Wilson. 1998. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Investig. 102:874-880.
3. Batoni, G., G. Maisetta, S. Esin, and M. Campa. 2006. Human beta-defensin-3: a promising antimicrobial peptide. Mini Rev. Med. Chem. 6:1063-1073.
4. Bonass, W. A., A. S. High, P. J. Owen, and D. A. Devine. 1999. Expression of beta-defensin genes by human salivary glands. Oral Microbiol. Immunol. 14:371-374.
5. Coleman, D. C., D. E. Bennett, D. J. Sullivan, P. J. Gallagher, M. C. Henman, D. B. Shanley, and R. J. Russell. 1993. Oral Candida in HIV infection and AIDS: new perspectives/ new approaches. Crit. Rev. Microbiol. 19:61-82.
6. Dale, B. A., and S. Krisanaprakornkit. 2001. Defensin antimicrobial peptide in the oral cavity. J. Oral Pathol. Med. 30:321-327.
7. Dunsche, A., Y. Acil, R. Siebert, J. Harder, J. M. Schroder, and S. Jepsen. 2001. Expression profile of human defensins and antimicrobial proteins in oral tissues. J. Oral Pathol. Med. 30:154-158.
8. Ganz, T. 2004. Defensins: antimicrobial peptides of vertebrates. C. R. Biol. 327:539-549.
9. Goldman, M. J., G. M. Anderson, E. D. Stolzenberg, U. P. Kari, M. Zasloff, and J. M. Wilson. 1997. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553-560.
10. Harder, J., J. Bartels, E. Christophers, and J. M. Schröder. 1997. A peptide antibiotic from human skin. Nature 387:861-862.
11. Harder, J., J. Bartels, E. Christophers, and J. M. Schröder. 2001. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:5707-5713.
12. Hoover, D. M., Z. Wu, K. Tucker, W. Lu, and J. Lubkowski. 2003. Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob. Agents Chemother. 47:2804-2809.
13. Kluver, E., K. Adermann, and A. Schulz. 2006. Synthesis and structure-activity relationship of β-defensins, multi-functional peptides of the immune system. J. Pept. Sci. 12:243-257.
14. Kluver, E., S. Schulz-Maronde, S. Scheid, B. Meyer, W. G. Forssmann, and K. Adermann. 2005. Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry 44:9804-9816.
15. Krishnakumari, V., A. Sharadadevi, S. Singh, and R. Nagaraj. 2003. Single disulfide and linear analogues corresponding to the carboxy-terminal segment of bovine β-defensin-2: effects of introducing the beta hairpin nucleating sequence D-Pro-Gly on antibacterial activity and biophysical properties. Biochemistry 42:9307-9315.
16. Krishnakumari, V., S. Singh, and R. Nagaraj. 2006. Antibacterial activities of synthetic peptides corresponding to the carboxy-terminal region of human beta-defensins 1-3. Peptides 27:2607-2613.
17. Lehrer, R. I. 2004. Primate defensins. Nat. Rev. Microbiol. 2:727-738.
18. Lehrer, R. I., and T. Ganz. 2002. Defensins of vertebrate animals. Curr. Opin. Immunol. 14:96-102.
19. Lehrer, R. I., T. Ganz, D. Szklarek, and M. E. Selsted. 1988. Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J. Clin. Investig. 81:1829-1835.
20. Lupetti, A., R. Danesi, J. W. van't Wout, J. T. van Dissel, S. Senesi, and P. H. Nibbering. 2002. Antimicrobial peptides: therapeutic potential for the treatment of Candida infections. Expert Opin. Investig. Drugs 11:309-318.
21. Mandal, M., M. V. Jagannadham, and R. Nagaraj. 2002. Antibacterial activities and conformations of bovine beta-defensin BNBD-12 and analogs: structural and disulfide bridge requirements for activity. Peptides 23:413-418.
22. Mandal, M., and R. Nagaraj. 2002. Antibacterial activities and conformations of synthetic alpha-defensin HNP-1 and analogs with one, two and three disulfide bridges. J. Pept. Res. 59:95-104.
23. Mathews, M., H. P. Jia, J. M. Guthmiller, G. Losh, S. Graham, G. K. Johnson, B. F. Tack, and P. B. McCray, Jr. 1999. Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect. Immun. 67:2740-2745.
24. Oppenheim, J. J., A. Biragyn, L. W. Kwak, and D. Yang. 2003. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann. Rheum. Dis. 62:17-21.
25. Pazgier, M., D. M. Hoover, D. Yang, W. Lu, and J. Lubkowski. 2006. Human beta-defensins. Cell. Mol. Life Sci. 63:1294-1313.
26. Pazgier, M., X. Li, W. Lu, and J. Lubkowski. 2007. Human defensins: synthesis and structural properties. Curr. Pharm. Des. 13:3096-3118.
27. Sahasrabudhe, K. S., J. R. Kimball, T. H. Morton, A. Weinberg, and B. A. Dale. 2000. Expression of the antimicrobial peptide, human beta-defensin-1, in duct cells of minor salivary glands and detection in saliva. J. Dent. Res. 79:1669-1674.
28. Sahl, H. G., U. Pag, S. Bonness, S. Wagner, N. Antcheva, and A. Tossi. 2005. Mammalian defensins: structures and mechanism of antibiotic activity. J. Leukoc. Biol. 77:466-475.
29. Schneider, J. J., A. Unholzer, M. Schaller, M. Schafer-Korting, and H. C. Korting. 2005. Human defensins. J. Mol. Med. 83:587-595.
30. Selsted, M., and A. J. Ouellette. 2005. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6:551-557.
31. Thevissen, K., F. R. Terras, and W. F. Broekaert. 1999. Permeabilization of fungal membranes by plant defensins inhibits fungal growth. Appl. Environ. Microbiol. 65:5451-5458.
32. Varkey, J., and R. Nagaraj. 2005. Antibacterial activity of human neutrophil defensin HNP-1 analogs without cysteines. Antimicrob. Agents Chemother. 49:4561-4566.
33. Vylkova, S., N. Nayyar, W. Li, and M. Edgerton. 2007. Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption. Antimicrob. Agents Chemother. 51:154-161.
34. Weber, P. J. A., J. E. Bader, G. Folkers, and A. G. Beck-Sickinger. 1998. A fast and inexpensive method for N-terminal fluorescein-labeling of peptides. Bioorg. Med. Chem. Lett. 8:597-600.
35. Wu, Z., D. M. Hoover, D. Yang, C. Boulegue, F. Santamaria, J. J. Oppenheim, J. Lubkowski, and W. Lu. 2003. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc. Natl. Acad. Sci. USA 100:8880-8885.
36. Zou, G., E. de Leeuw, C. Li, M. Pazgier, C. Li, P. Zeng, W.-Y. Lu, J. Lubkowski, and W. Lu. 2007. Toward understanding the cationicity of defensins: Arg and Lys versus their noncoded analogs. J. Biol. Chem. 282:19653-19665.